Patent licenses; non-exclusive, exclusive, or partially exclusive: Method for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections with bovine erythrocyte preparations,

[Federal Register: February 10, 2003 (Volume 68, Number 27)]

[Notices]

[Page 6724-6725]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr10fe03-55]

DEPARTMENT OF DEFENSE

Department of the Army

Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Method for Treating, Preventing, or Inhibiting Enterotoxigenic Escherichia Coli Infections With Bovine Erythrocyte Preparations

AGENCY: Department of the Army, DoD.

ACTION: Notice.

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent Application No. 10/077,804 entitled ``Method for Treating, Preventing, or Inhibiting Enterotoxigenic Escherichia Coli Infections with Bovine Erythrocyte Preparations,'' filed February 20, 2002. The United States Government, as represented by the Secretary of the Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: This invention relates generally to bovine erthrocyte preparations. In particular, the present invention relates to methods of using bovine erythrocyte preparations for treating, preventing, or inhibiting

[[Page 6725]]

enterotoxigenic Escherichia coli infections.

Luz D. Ortiz, Army Federal Register Liaison Officer.

[FR Doc. 03-3244 Filed 2-7-03; 8:45 am]

BILLING CODE 3710-08-M

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT